These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1115 related items for PubMed ID: 17472823

  • 21. The long-term efficacy of insulin glargine plus oral antidiabetic agents in a 32-month observational study of everyday clinical practice.
    Schreiber SA, Ferlinz K, Haak T.
    Diabetes Technol Ther; 2008 Apr; 10(2):121-7. PubMed ID: 18260775
    [Abstract] [Full Text] [Related]

  • 22. Fixed-dose combination antidiabetic therapy: real-world factors associated with prescribing choices and relationship with patient satisfaction and compliance.
    Benford M, Milligan G, Pike J, Anderson P, Piercy J, Fermer S.
    Adv Ther; 2012 Jan; 29(1):26-40. PubMed ID: 22246944
    [Abstract] [Full Text] [Related]

  • 23. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
    Turner RC, Cull CA, Frighi V, Holman RR.
    JAMA; 1999 Jun 02; 281(21):2005-12. PubMed ID: 10359389
    [Abstract] [Full Text] [Related]

  • 24. Multicenter retrospective assessment of thiazolidinedione monotherapy and combination therapy in patients with type 2 diabetes: comparative subgroup analyses of glycemic control and blood lipid levels.
    Olansky L, Marchetti A, Lau H.
    Clin Ther; 2003 Jun 02; 25 Suppl B():B64-80. PubMed ID: 14553867
    [Abstract] [Full Text] [Related]

  • 25. Achieving glycemic goal with initial versus sequential combination therapy using metformin and pioglitazone in type 2 diabetes mellitus.
    Pandya BJ, Bron M, McCall T, Yu AP, Chen KS, Mattson ME, Wu EQ.
    Curr Med Res Opin; 2011 Jan 02; 27(1):189-95. PubMed ID: 21142610
    [Abstract] [Full Text] [Related]

  • 26. Attainment of glycaemic goals in type 2 diabetes with once-, twice-, or thrice-daily dosing with biphasic insulin aspart 70/30 (The 1-2-3 study).
    Garber AJ, Wahlen J, Wahl T, Bressler P, Braceras R, Allen E, Jain R.
    Diabetes Obes Metab; 2006 Jan 02; 8(1):58-66. PubMed ID: 16367883
    [Abstract] [Full Text] [Related]

  • 27. Exenatide added to insulin therapy: a retrospective review of clinical practice over two years in an academic endocrinology outpatient setting.
    Yoon NM, Cavaghan MK, Brunelle RL, Roach P.
    Clin Ther; 2009 Jul 02; 31(7):1511-23. PubMed ID: 19695400
    [Abstract] [Full Text] [Related]

  • 28. Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysis.
    Karagiannis T, Paschos P, Paletas K, Matthews DR, Tsapas A.
    BMJ; 2012 Mar 12; 344():e1369. PubMed ID: 22411919
    [Abstract] [Full Text] [Related]

  • 29. Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study.
    Mattoo V, Eckland D, Widel M, Duran S, Fajardo C, Strand J, Knight D, Grossman L, Oakley D, Tan M, H6E-MC-GLAT study group.
    Clin Ther; 2005 May 12; 27(5):554-67. PubMed ID: 15978304
    [Abstract] [Full Text] [Related]

  • 30. Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study.
    Williams-Herman D, Johnson J, Teng R, Luo E, Davies MJ, Kaufman KD, Goldstein BJ, Amatruda JM.
    Curr Med Res Opin; 2009 Mar 12; 25(3):569-83. PubMed ID: 19232032
    [Abstract] [Full Text] [Related]

  • 31. Treatment intensification in patients with type 2 diabetes who failed metformin monotherapy.
    Fu AZ, Qiu Y, Davies MJ, Radican L, Engel SS.
    Diabetes Obes Metab; 2011 Aug 12; 13(8):765-9. PubMed ID: 21457427
    [Abstract] [Full Text] [Related]

  • 32. Efficacy and safety profile of exenatide once weekly compared with insulin once daily in Japanese patients with type 2 diabetes treated with oral antidiabetes drug(s): results from a 26-week, randomized, open-label, parallel-group, multicenter, noninferiority study.
    Inagaki N, Atsumi Y, Oura T, Saito H, Imaoka T.
    Clin Ther; 2012 Sep 12; 34(9):1892-908.e1. PubMed ID: 22884767
    [Abstract] [Full Text] [Related]

  • 33. Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.
    Blak BT, Smith HT, Hards M, Curtis BH, Ivanyi T.
    Diabet Med; 2012 Jul 12; 29(7):e13-20. PubMed ID: 22268988
    [Abstract] [Full Text] [Related]

  • 34. Pioglitazone is effective therapy for elderly patients with type 2 diabetes mellitus.
    Rajagopalan R, Perez A, Ye Z, Khan M, Murray FT.
    Drugs Aging; 2004 Jul 12; 21(4):259-71. PubMed ID: 15012171
    [Abstract] [Full Text] [Related]

  • 35. Combination of oral antidiabetic agents with basal insulin versus premixed insulin alone in randomized elderly patients with type 2 diabetes mellitus.
    Janka HU, Plewe G, Busch K.
    J Am Geriatr Soc; 2007 Feb 12; 55(2):182-8. PubMed ID: 17302653
    [Abstract] [Full Text] [Related]

  • 36. Initiating insulin therapy in type 2 Diabetes: a comparison of biphasic and basal insulin analogs.
    Raskin P, Allen E, Hollander P, Lewin A, Gabbay RA, Hu P, Bode B, Garber A, INITIATE Study Group.
    Diabetes Care; 2005 Feb 12; 28(2):260-5. PubMed ID: 15677776
    [Abstract] [Full Text] [Related]

  • 37. Long-term effects of glimepiride or rosiglitazone in combination with metformin on blood pressure control in type 2 diabetic patients affected by the metabolic syndrome: a 12-month, double-blind, randomized clinical trial.
    Derosa G, Cicero AF, Gaddi AV, Ciccarelli L, Piccinni MN, Salvadeo S, Pricolo F, Fogari E, Ghelfi M, Ferrari I, Fogari R.
    Clin Ther; 2005 Sep 12; 27(9):1383-91. PubMed ID: 16291411
    [Abstract] [Full Text] [Related]

  • 38. Vildagliptin plus metformin combination therapy provides superior glycaemic control to individual monotherapy in treatment-naive patients with type 2 diabetes mellitus.
    Bosi E, Dotta F, Jia Y, Goodman M.
    Diabetes Obes Metab; 2009 May 12; 11(5):506-15. PubMed ID: 19320662
    [Abstract] [Full Text] [Related]

  • 39. Glycemic control with insulin glargine plus insulin glulisine versus premixed insulin analogues in real-world practices: a cost-effectiveness study with a randomized pragmatic trial design.
    Levin PA, Zhang Q, Mersey JH, Lee FY, Bromberger LA, Bhushan M, Bhushan R.
    Clin Ther; 2011 Jul 12; 33(7):841-50. PubMed ID: 21719107
    [Abstract] [Full Text] [Related]

  • 40. Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study.
    Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, Zagar T, Poole CD.
    Lancet; 2010 Feb 06; 375(9713):481-9. PubMed ID: 20110121
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 56.